Jump to: Page Content, Site Navigation, Site Search,
You are seeing this message because your web browser does not support basic web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.
![]()
Professor Robin Spiller is currently a Professor in Gastroenterology at the University of Nottingham, UK. He did his undergraduate training at Cambridge University and clinical studies at University College. His clinical training was in London which included a year as a Medical Research Council Travelling Fellow to the Mayo Clinic, Rochester, USA . He was appointed Consultant Gastroenterologist at University Hospital, Nottingham in 1988.
He is a member of the British and American Societies of Gastroenterology and the European society of Neurogastroenterology and Motility; Past Chairman of the Neurogastroenterology and Motility Section of the British Society of Gastroenterology (BSG) He edited the BSG Guidelines for the management of IBS and is a member of the Co-ordinating Committee of the Rome Foundation, an international group which produced the Rome III criteria for the classification of the functional GI diseases. He has been Editor of Gut and international journal of Gastroenterology and Hepatology since 2003. He is the author/co-author of more than 182 scientific publications. His main interest is in gut physiology and functional GI diseases. He has shown the role of inflammation and abnormalities of serotonin and secretion in the irritable bowel syndrome. He has also a longstanding collaboration with the Sir Peter Mansfield Magnetic Resonance Imaging Centre which has exploited the capabilities of MRI to study upper GI physiology in health and disease. The research has focused particularly on the effect of the physical form of food on digestion and satiety.
Read articles by Robin Spiller
| Competing Interests |
|---|
| Have you in the past five years accepted the following from an organisation that may in any way gain or lose financially from the publication of papers in the BMJ? |
| a) Reimbursement for attending a symposium? |
| No |
| b) A fee for speaking? |
| No |
| c) A fee for organising education? |
| No |
| d) Funds for research? |
|
Professor Spiller had received research funding from Glaxo Smith Kline Research and Development Ltd and Novartis Pharmaceuticals. |
| e) Funds for a member of staff? |
| No |
| f) Fees for consulting? |
| No |
| Have you in the past five years been employed by any organisation that may in any way gain or lose financially from the publication of papers in the BMJ? |
| No |
| a) Do you hold any stocks or shares in an organisation? |
| No |
| b) Do you have any other competing financial interests? |
| No |